trending Market Intelligence /marketintelligence/en/news-insights/trending/tl9XGCrCtlRUxHf3kjDCbA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

JobLocationMap Q1 loss narrows YOY

Mining Exploration Insights - November 2020

Southeast Asian broadband providers report varying performance amid COVID-19

Cable networks react to pandemic by cutting SG&A, programming costs

Infographic: 2020 Global Mining Exploration Trends


JobLocationMap Q1 loss narrows YOY

Bioscience Neutraceuticals Inc. said its first-quarter normalized net income was a loss of $2,180, compared with a loss of $2,320 in the year-earlier period.

Normalized net income excludes unusual gains or losses on a pre- and after-tax basis.

Reported net income totaled a loss of $3,500, or a loss of 0 cents per share, compared to a loss of $3,710, or a loss of 0 cents per share, in the year-earlier period.